Jung-Min Ahn , MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  1. Left Main AMI with Cardiogenic Shock, How to Rescue?
  2. Choosing Wisely: FFR vs. Anatomy Dilemma in LM PCI and Introduction to FATE-MAIN Trial
  3. Precision in Stent Sizing: Insights from Imaging-Guided LM PCI
  4. TAVR for Bicuspid AV: What¡¯s Different?
  5. Synergetic Approach for Discordant Lesions Between FFR and Hyperemia Free Indexes
  6. ASSURE-DES Trial
  7. 10-Year Extended Follow-up of BEST Trial
  8. Defining Lesion Severity (by Angiography, Physiology & IVUS)
  9. Not to Treat
  10. Optimal MSA for LM Crush Technique: New Criteria Any Difference in Any 2 Stent Technique?
  11. TAVR Techniques in Bicuspid Anatomy – Valve Selection, Sizing, and Positioning
  12. How to Optimize 1st Valve Choice Matter for Future
  13. How Can We Treat Patients with Concomitant Coronary Artery Disease?
  14. Low Penetration of FFR (1A Class) in Real Practice; Why and How to Overcome?
  15. Case 4. CTO
  16. CTO Revascularization 2022: Guidelines and Concept Change
  17. Physiologic Approach For Non-LM Bifurcation Disease
  18. Unmet Need for FFR in LM PCI
  19. Minimalist TAVI : Achieving Great TAVI Efficiency and Optimal Patient Outcome
  20. Ÿºñ ½Ã¼úÀ» À§ÇÑ CT Æò°¡
  21. TAVR for Bicuspid Valve: Practical Tips and Tricks for Optimal Sizing and Positioning
  22. FFR is a Routine Cath Lab Procedure
  23. FFR, It\'s Standard
  24. The Basics of Coronary Physiology Measurement: FFR, iFR and other NHPRs
  25. Updated Imaging/Physiology-Guided PCI Tuning 2021
  26. Under Pressure: Optimal Post-Dilation Strategy
  27. Difficult Wiring, Tips and Tricks
  28. TAVR for Bicuspid AS: Optimal Sizing & Valve Selection
  29. Imaging-guided PSP for Optimizing PCI
  30. How to Treat Tandem Lesion Under Physiology-Guidance
  31. Guide Extension Catheters: Strong Support from Mother-Child Relationship
  32. Post TAVR Coronary Access with Evolut System
  33. Self-Expandable Evolut R & PRO Valve
  34. TAVR for Bicuspid AV: Tips and Tricks
  35. Bifurcation PCI: Contemporary Practical Approach
  36. The Role of Debulking Atherectomy for Calcific In-stent Restenosis
  37. Prognosis of Discordant Lesion Between FFR and Hyperemia Free Indexes
  38. [Case-based Debate: Intracoronary Imaging Modalities for PCI Guidance] IVUS Is Better!
  39. Clinically Relevant PeriProcedural MI: Practical and Clinical Trial Aspect
  40. Case 1: Unexpanded ISR - Challenging and Optimal Treatment
  41. How Do I Implement?: FFR and Various Non-hyperemic Diastolic Index
  42. Current Status of Balloon-Expandable TAVR in Korea
  43. OAC in TAVR: FAILED GALILEO - NOAC Don\'t Work or Other Options?
  44. TAVR for Bicuspid AV: Tips and Tricks
  45. Synergetic Approach for Discordant Lesions Between FFR and Hyperemia Free Indexes
  46. Guide Extension Catheters: A Strong Support from a Parent-Child Relationship
  47. Expert Case Review: Complex PCI for Severe Calcified Coronary Disease
  48. Expert Case Review: Complex Bifurcation PCI
  49. Impact of Renal Function on Stroke or Systemic Embolism Following TAVR
  50. TAVR for Bicuspid Valve: Clinical Outcome and Technical Considerations
  51. TAVR: Bicuspid, Severe Calcium, and Low Lying Left Main
  52. TAVR in Bicuspid Aortic Stenosis with Severe Calcification: Case Reviews and Tips-and-Tricks
  53. How About Integrated Use of Resting Pd/Pa and FFR?
  54. Distal Left Main Bifurcation PCI: Concept Is More Important.
  55. [Case #2: Transcatheter Aortic Valve Implantation in a Patient with Type B Aortic Dissection] Part 2. How Would I Treat?
  56. FFR as the Gold Standard Index!
  57. Five-Year Outcomes of Routine FFR Use in Clinical Practice: Data from ASAN PCI Registry
  58. The Benefit of Complete Revascularization in Complex Coronary Artery Disease
  59. Asian Pacific TAVR Registry
  60. [Taped Case] TAVR with Evolut R
  61. Bicuspid AS: Future Perspectives of TAVR
  62. Integrated Use of FFR and IVUS for LM PCI
  63. Bicuspid TAVR Registry and TRANSIT Trial: TAVI Experience in AMC
  64. Bicuspid and Valve-in-Valve; How Different?
  65. Clinical Outcome of DEFER
  66. Left Main and MVD PCI: Imaging and Functional Guidance
  67. Utility of Intravascular Imaging for Resolving Issues During PCI
  68. Long Lesion and Tandem Lesion
  69. Bicuspid TAVR Registry
  70. AP TAVR Registry
  71. Current Status of TAVR: High/Intermediate and Lower Risk
  72. Clinical Impact of Routine FFR Measurement
  73. Tandem
  74. Prognostic Value of FFR: Insight from IRIS-FFR Registry
  75. Practical Aspect of IMR in AMI and Stable Angina
  76. Elderly Population
  77. LM PCI 2016: Integrated Approach Using IVUS, FFR and New Imaging Modality
  78. [Review in 2015] Physiology
  79. Tandem Lesion Evaluation
  80. Integrated Use of IVUS and FFR in Real Practice
  81. Readmission After PCI or CABG
  82. Left Main
  83. Final Answer RESTORE
  84. Comparative Outcomes of Various DES from IRIS-MAIN Registry and PRECOMBAT Series
  85. Case Presentation 4: Medically Stabilized Type A Aortic Dissection After TAVI
  86. Randomzed Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: Five-Year Outcomes of the PRECOMBAT Study
  87. Preliminary Data from IRIS FFR Registry
  88. Complex Lesions, Left Main, Bifurcations, Tandem, and More
  89. Left Main PCI
  90. Understanding About Visual-Functional Mismatching
  91. TAVI for Bicuspid Valve Stenosis
  92. FFR-guided PCI in Routine Practice: Learn from AMC Experiences
  93. Is There a Generation Gap of DES: Results of PRECOMBAT Study Series
  94. Clinical Implementation of FFR
  95. Case-based Review: Incidence and Treatment of LM ISR
  96. LM & Tandem Lesion
  97. VH IVUS: Native Plaque and Neointima
  98. Clinical Evidence of Neoatherosclerosis: ISR and Late Stent Thrombosis
  99. LM PCI
  100. IRIS-ELEMENT Data Review
  101. Cross and Perfect: 2013 Update
  102. Anatomical - Functional Stenosis: How Much Discordant?
  103. Case Presentation: Functional Angioplasty
  104. Impact of Functional Angioplasty on Clinical Outcomes of PCI
  105. Novice's Trial of Complex LM PCI
  106. New-generation DES for Long Lesions: From a Large-scale Cohort Regis
  107. FFR Utilization in LM PCI
  108. Promus Element Clinical Program in Asan Medical Center
  109. FFR-guided PCI in Tandem Lesion
  110. Two Cases with Coronary Thromboembolism
  111. Does the Timing of IABP Matter?